Transparency Market Research in its new report titled, “Barbiturate Anticonvulsants Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 – 2026,” provides key insights on the barbiturate anticonvulsants drugs market. The TMR report anticipates that the rising prevalence of seizures across the world will drive the barbiturate anticonvulsants drugs market during the forecast period i.e, 2018-2026. Every year, 30 to 50 per 100000 people are newly diagnosed with epilepsy in high-income countries, and this count is approximately two times higher among low and middle income countries. Ketogenic diet is anticipated to restrain the growth of the global barbiturate anticonvulsants drugs market to a certain extent. According to a study published by the National Center for Biotechnology Information, ketogenic diet reduces the chances of seizures in children, says the report.
The TMR report has segmented the global barbiturate anticonvulsant drugs market into indication, distribution channel, and region. On the basis of indication, the market is classified into generalized seizures and focal (partial) seizures. Generalized seizures can further be classified into tonic-clonic seizure, atonic seizure, myoclonic seizure, clonic seizure, and tonic seizure. Focal seizures can further be classified into dyscognitive focal seizures and simple focal seizures. In terms of distribution channel, the barbiturate anticonvulsant drugs market is divided into retail pharmacies, online pharmacies, and hospital pharmacies. On a geographical stand, the global barbiturate anticonvulsant drugs market is categorized into Latin America, Asia Pacific, Europe, North America, and Middle East & Africa. North America held the large market share in 2017, due to new drug launches and increase in research and development on barbiturate anticonvulsant drugs in the region.
Europe held the second leading market share in 2017, owing to the increase in awareness programs and promotional activities conducted by the key players in the region. Asia Pacific is anticipated to grow at a significant rate during the forecast period owing to increase in government initiatives to create awareness regarding the barbiturate anticonvulsant drugs, especially in countries, such as China and India. Japan held the maximum share of the barbiturate anticonvulsant drugs market in Asia Pacific in 2017, owing to the large geriatric population in the country. The barbiturate anticonvulsant drugs market in Middle East & Africa and Latin America is anticipated to grow at a moderate rate during the forecast period owing to rise in government initiatives regarding development of and creating awareness barbiturate anticonvulsants drugs in the regions. Some of the major players operating in the global barbiturate anticonvulsants drugs market are profiled in this report to give a better competitive analysis and these include GlaxoSmithKline plc, Astellas Pharma Technologies Inc., Valeant Pharmaceuticals N.A., and Watson Laboratories, Inc.
About Us
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: [email protected]